©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2015; 3(10): 900-903
Published online Oct 16, 2015. doi: 10.12998/wjcc.v3.i10.900
Published online Oct 16, 2015. doi: 10.12998/wjcc.v3.i10.900
Acute hepatitis after amiodarone infusion
Paulo Fonseca, Adelaide Dias, Helena Gonçalves, Aníbal Albuquerque, Vasco Gama, Cardiology Department, Gaia Hospital Center, 4434-502 Vila Nova de Gaia, Portugal
Author contributions: Fonseca P, Dias A and Gonçalves H wrote the case report; Albuquerque A and Gama V revised the manuscript.
Institutional review board statement: IRB approval was not required for this case report.
Informed consent statement: The patient gave his informed consent to the publication of this clinical case.
Conflict-of-interest statement: The authors declare that there is no conflict of interests regarding the publication of this article.
Correspondence to: Paulo Fonseca, MD, Cardiology Department, Gaia Hospital Center, Rua Conceição Fernandes, 4434-502 Vila Nova de Gaia, Portugal. paulobarbosafonseca@hotmail.com
Telephone: +351-22-7865100 Fax: +351-22-7830209
Received: January 20, 2015
Peer-review started: January 21, 2015
First decision: March 6, 2015
Revised: April 18, 2015
Accepted: August 10, 2015
Article in press: August 11, 2015
Published online: October 16, 2015
Processing time: 269 Days and 9.2 Hours
Peer-review started: January 21, 2015
First decision: March 6, 2015
Revised: April 18, 2015
Accepted: August 10, 2015
Article in press: August 11, 2015
Published online: October 16, 2015
Processing time: 269 Days and 9.2 Hours
Core Tip
Core tip: We report a rare case of acute hepatitis induced by intravenous amiodarone in a patient with non-sustained ventricular tachycardia. The physiopathology of this adverse effect is still unclear. Close monitoring of hepatic function during amiodarone infusion is essential to avoid any potential hepatotoxicity.